It is highly possible that targeting Smad3 with Smad3 inhibitors such as SIS3 inhibits renal fibrosis as well as acute kidney injury via a mechanism associated with GPX4-dependent ferroptosis as seen in this study and other previous reports. The gene discussed is GPX4; the disease is renal fibrosis.